BioCardia elects Marvin Slosman to board; Dr. Richard Krasno completes term

BioCardia, Inc.

Marvin Slosman, CEO of InspireMD, elected to BioCardia board effective Dec. 2, 2025.
Dr. Richard Krasno, a director since 2016, completed his term and departed the board on Dec. 2, 2025.
At the annual meeting, shareholders elected Slosman, Jay M. Moyes, and Simon H. Stertzer as Class III directors.
Shareholders also approved amendment to 2016 Equity Incentive Plan extending term to 2035 and increasing share reserve.
Ratification of PKF San Diego as auditor approved; advisory vote on executive compensation passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.